The Latest Breaking News from AstraZeneca

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

Secretary of State Antony Blinken spent the weekend in China meeting top Chinese officials, including President Xi Jinping.

UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions

Stock futures edge higher as jobs report, debt deal boost global markets; Week Ahead: inflation data, Treasury bond sales in focus; Saudi Arabia agrees steep production cuts as OPEC seeks to 'stabilize' global markets; Palo Alto Networks leaps on S&P 500 inclusion, DISH Networks slumps and AstraZeneca unveils 'unprecedented' data…

The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death, study shows.

BEIJING: The global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said on Friday.

To better weather future pandemics, the way countries procure vaccines needs to change radically

Sanofi said Friday its shot significantly reduced the risk of babies becoming hospitalized with RSV. But Sanofi stock dipped Friday.